Lemaitre Vascular Inc Quick Ratio (LMAT) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Lemaitre Vascular Inc   (NASDAQ: LMAT)

Lemaitre Vascular Inc 's Quick Ratio

LMAT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 11.26 above Lemaitre Vascular Inc average.

Within Medical Equipment & Supplies industry 8 other companies have achieved higher Quick Ratio than Lemaitre Vascular Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 313 to 379.

Explain Quick Ratio?
How much Cash & cash equivalents LMAT´s has?
What are LMAT´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/LMAT/financial-strength
https://api.csimarket.com/api/v1/companies/LMAT/fundamentals
https://api.csimarket.com/api/v1/companies/LMAT/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
LMAT Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 4 %
Y / Y Cash & cash equivalent Change 13.6 %
Quick Ratio MRQ 11.26
LMAT's Total Ranking # 379
Seq. Current Liabilities Change 15.65 %
Seq. Cash & cash equivalent Change 3.58 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 9
Healthcare Sector # 129
Overall Market # 379


Quick Ratio Statistics
High Average Low
14.56 3.96 0.56
(Sep 30 2011)   (Jun 30 2020)




Financial Statements
Lemaitre Vascular Inc 's Current Liabilities $ 35 Millions Visit LMAT's Balance sheet
Lemaitre Vascular Inc 's Cash & cash equivalent $ 390 Millions Visit LMAT's Balance sheet
Source of LMAT's Sales Visit LMAT's Sales by Geography


Cumulative Lemaitre Vascular Inc 's Quick Ratio

LMAT's Quick Ratio for the trailling 12 Months

LMAT Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 12.38 %
Y / Y Cash & cash equivalent TTM Growth 17.99 %
Quick Ratio TTM 11.12
Total Ranking TTM # 3985
Seq. Current Liabilities TTM Growth 1 %
Seq. Cash & cash equivalent TTM Growth 3.23 %


On the trailing twelve months basis LMAT Cash & cash equivalent increased by 13.6 % in Q3 2026 year on year, faster than Current Liabilities, this led to increase in in Lemaitre Vascular Inc 's Quick Ratio to 11.12, above LMAT average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 203 other companies have achieved higher Quick Ratio than Lemaitre Vascular Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3238 to 3985.

Explain Quick Ratio?
How much Cash & cash equivalents LMAT´s has?
What are LMAT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 204
Healthcare Sector # 898
Within the Market # 3985


trailing twelve months Quick Ratio Statistics
High Average Low
2.88 1.47 0.54
(Sep 30 2012)   (Jun 30 2020)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Microbot Medical Inc   14.71 $ 62.649  Millions$ 4.260  Millions
Bone Biologics Corporation  12.66 $ 6.088  Millions$ 0.481  Millions
Vivos Inc  11.65 $ 1.807  Millions$ 0.155  Millions
Anteris Technologies Global Corp   11.37 $ 216.987  Millions$ 19.085  Millions
Lemaitre Vascular Inc   11.26 $ 389.721  Millions$ 34.620  Millions
Mobia Medical Inc   10.63 $ 160.692  Millions$ 15.115  Millions
Axogen inc   9.55 $ 348.068  Millions$ 36.456  Millions
Delcath Systems Inc   8.01 $ 104.315  Millions$ 13.022  Millions
Orchestra Biomed Holdings Inc   7.16 $ 101.907  Millions$ 14.228  Millions
Envveno Medical Corporation  7.13 $ 18.472  Millions$ 2.589  Millions
Ceribell Inc   6.51 $ 117.467  Millions$ 18.034  Millions
Autonomix Medical Inc   6.13 $ 7.692  Millions$ 1.254  Millions
Iradimed Corporation  6.13 $ 63.288  Millions$ 10.323  Millions
Orasure Technologies Inc  5.90 $ 148.238  Millions$ 25.104  Millions
Perspective Therapeutics Inc   5.09 $ 201.695  Millions$ 39.602  Millions
Beyond Air Inc   4.69 $ 17.121  Millions$ 3.647  Millions
Clearpoint Neuro Inc   4.68 $ 46.184  Millions$ 9.869  Millions
Cvrx inc   4.67 $ 58.746  Millions$ 12.583  Millions
Heartbeam Inc   4.47 $ 6.065  Millions$ 1.358  Millions
Dexcom Inc   4.25 $ 964.800  Millions$ 227.000  Millions
Innovative Eyewear Inc   3.86 $ 3.197  Millions$ 0.829  Millions
Sight Sciences Inc   3.84 $ 77.402  Millions$ 20.137  Millions
Bluejay Diagnostics Inc  3.83 $ 7.380  Millions$ 1.927  Millions
Alpha Pro Tech Ltd   3.78 $ 25.546  Millions$ 6.750  Millions
Hyperfine Inc   3.60 $ 37.872  Millions$ 10.532  Millions
Capsovision Inc   3.55 $ 21.757  Millions$ 6.124  Millions
Profound Medical Corp   3.41 $ 33.343  Millions$ 9.771  Millions
Rxsight Inc   3.40 $ 254.683  Millions$ 74.952  Millions
Omada Health Inc   3.23 $ 243.151  Millions$ 75.379  Millions
Transmedics Group Inc   3.22 $ 492.962  Millions$ 152.857  Millions

Date modified: 2026-11-08T19:32:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.